14 December 2023 in International Journal of Endocrinology
Objective. To investigate the relationship between glucagon-like peptide-1 receptor gene polymorphisms and susceptibility to early onset type 2 diabetes. Methods. Samples from 316 type 2 diabetes patients with early onset type 2 diabetes (n=137) and late-onset type 2 diabetes (n=179) and 145 nondiabetic individuals were analyzed. Multiplex PCR combined with resequencing Hi-Reseq technology was used to detect single nucleotide polymorphisms of the glucagon-like peptide-1 receptor gene, and the allele frequency, genotype distribution, and clinical parameters were analyzed between each diabetes subgroup and the control group. Results. Sixteen single nucleotide polymorphisms were identified in the exonic region of the glucagon-like peptide-1 receptor gene according to the minor allele frequency (MAF>0.05) in the participants. Among these, the glucagon-like peptide-1 receptor rs3765467 (GA) mutation was statistically associated with early onset type 2 diabetes. Compared with that of the GG carriers, carriers of genotype AA at rs3765467 had a decreased risk of early onset type 2 diabetes after adjusting for sex and body mass index. In the dominant model, the frequencies of the rs3765467 AA+GA genotype were significantly decreased in the early onset type 2 diabetes group, and carriers of genotype AA+GA at rs3765467 had a decreased risk of early onset type 2 diabetes after adjusting for sex and body mass index. Moreover, fasting C peptide levels were significantly higher in GA+AA genotype carriers than those in GG genotype carriers. Conclusion. The glucagon-like peptide 1 receptor rs3765467 polymorphism was significantly associated with age at type 2 diabetes diagnosis and thus may be used as a marker to screen and detect individuals at risk of developing early onset type 2 diabetes.
26 December 2025 in Medicine
OSBPL3 is vital for fatty liver disease, but its immune mechanisms in metabolic dysfunction-associated steatotic liver disease (MASLD) are unclear. This study investigates these mechanisms for MASLD treatment insights. MASLD datasets from public databases were used. OSBPL3 expression was analyzed by t -test in GSE57425, and its function explored via GSEA. Key cell types were identified in GSE129516 by scRNA-seq, followed by cell-to-cell communication and pseudo-temporal analyses. OSBPL3 expression differed significantly between high-fat and normal diet groups ( P = .00048). It was enriched in the “oxidative phosphorylation” pathway, hinting at its role in energy metabolism and mitochondrial function in MASLD. Thirteen cell types were identified, with macrophages and monocytes as key types due to expression and cell percentage differences. Macrophages showed closer communication with granulocytes, fibroblasts, and erythrocytes in nonalcoholic steatohepatitis (NASH) diet samples. Macrophage and monocyte differentiation had 9 distinct states, with OSBPL3 highly expressed during metaphase. This study identified macrophages and monocytes as key cell types in OSBPL3’s mechanism in MASLD, offering valuable insights for targeted therapies.